JSE : Dealings in securities by directors, prescribed officers, the company secretary and the JSE LTIS 2018 Trust

JSE LIMITED

(Incorporated in the Republic of South Africa) Registration number: 2005/022939/06

Share Code: JSE

ISIN Code: ZAE000079711

LEI: 213800MZ1VUQEBWRFO39 ("JSE")

DEALINGS IN SECURITIES BY DIRECTORS, PRESCRIBED OFFICERS, THE COMPANY SECRETARY AND THE JSE LTIS 2018 TRUST

The JSE LTIS 2018 Trust ("Trust") has acquired 494 170 JSE ordinary shares in the open market on behalf of executive directors, members of the executive committee, the Company Secretary and senior members of staff ("LTIS 2018 participants") to fulfil share awards granted in March 2020 to these staff under the JSE's Long-Term Incentive Scheme ("LTIS 2018").

These ordinary shares are held in trust and are restricted until all vesting criteria are fulfilled whereupon the shares vest. To the extent that the vesting criteria are not fulfilled the share awards are forfeited.

The vesting of these restricted JSE ordinary shares is subject to -

1. the JSE achieving specified corporate performance targets over the measurement period; and
2. a LTIS 2018 participant remaining in the employ of the JSE for the vesting term (collectively "the vesting criteria").

These JSE ordinary shares were acquired on-market, with prior clearance, at a volume-weighted average price of R102.7343 per ordinary share. The total transaction value amounted to R50 768 209.03. The daily high, low and volume-weighted average for the various transactions were -

Dates in 2020	Number of JSE	Daily VWAP of	Daily high	Daily low
	that JSE	JSE shares
	ordinary	price paid	price paid
	ordinary	acquired
	shares	(cents per	(cents per
	shares	(cents per
	acquired	share)	share)
	acquired	share)
11	March	20 040	10389.56	10523	10290
12	March	182 066	10215.35	10322	9900
13	March	216 818	10524.00	10838	10059
16	March	75 246	9661.02	10235	9291

The requisite approvals have been granted by shareholders at the JSE's annual general meeting, in respect of the acquisition of JSE ordinary shares in the open market and in respect of specific financial assistance to the Trust for the purpose of acquiring these shares.

ACCEPTANCE OF ALLOCATIONS OF SECURITIES TO DIRECTORS, THE COMPANY SECRETARY AND PRESCRIBED OFFICERS

Following the acquisition of the JSE ordinary shares by the Trust as disclosed above, the executive directors, members of the executive committee and the Company Secretary have on 13 March 2020 accepted grants of restricted JSE ordinary shares, as reflected in this announcement.

		Total number	Total Rand value
		of restricted
		of restricted JSE
		JSE ordinary	Nature of
Executive	Role	ordinary shares
shares	interest
		awarded and
		awarded and
		accepted
		accepted
	Group CEO &				Direct
L Fourie	Executive	84 570	8 688	240
beneficial
	Director
A Takoordeen	CFO & Executive	24 916	2 559	728	Direct
Director	beneficial
A Greenwood	Prescribed	26 506	2 723	075	Direct
Officer	beneficial
D Khumalo	Prescribed	19 668	2 020	578	Direct
Officer	beneficial
H Kotze	Prescribed	22 962	2 358	985	Direct
Officer	beneficial
Z Morrison	Prescribed	16 060	1 649	913	Direct
Officer	beneficial
M Randall	Prescribed	20 754	2 132	148	Direct
Officer	beneficial
V Reddy	Prescribed	23 918	2 457	199	Direct
Officer	beneficial
GA Brookes	Group Company	11 794	1 211	648	Direct
Secretary	beneficial

The restricted shares will vest in two tranches, one-half on 1 March 2023 and the remaining half on 1 March 2024, subject to the vesting criteria as set out above being met.

The individual allocations (grant and acceptance) were approved by the JSE's Group Human Resources Committee and clearance to deal was granted by the Chairman of the Board.

Sandton

17 March 2020

Sponsor

RAND MERCHANT BANK (A division of FirstRand Bank Limited)